Pharmaceutical News and Articles

Arcutis’ Zoryve (roflumilast) Topical Foam 0.3% Approved by U.S. FDA for the Treatment of Plaque Psoriasis in Adults and Adolescents Ages 12 and Older

Celltrion's Yuflyma (adalimumab-aaty) Receives FDA Interchangeability Designation for All Approved Dosage Forms and Strengths

FDA Approves Yutrepia (treprostinil) Inhalation Powder for Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

FDA Approves Genentech’s Susvimo for Diabetic Retinopathy

FDA Approves Brekiya (dihydroergotamine mesylate) Injection for the Acute Treatment of Migraine and Cluster Headaches in Adults

Phase 3 Clinical Study of Mazdutide in Chinese Adults with Overweight or Obesity (GLORY-1) Published in The New England Journal of Medicine (NEJM)

SAN FRANCISCO, U.S., SUZHOU, China May 26, 2025 Innovent Biologics, Inc. ( Innovent ) (HKEX 01801), a world-class biopharmaceutical company that develops, manuf

Linvoseltamab in Combination with Carfilzomib or Bortezomib Shows Promising Initial Results in Earlier Lines of Treatment for Relapsed/Refractory Multiple Myeloma

Regeneron Pharmaceuticals, Inc. (NASDAQ REGN) today announced initial results from two cohorts of the Phase 1b LINKER-MM2 trial evaluating linvoseltamab in comb

Quieter Classrooms May Help Calm Kids, Study Shows

SUNDAY, May 25, 2025 The first day of preschool can be tough lots of new faces, unfamiliar sounds and the sudden goodbye to Mom or Dad can be overwhelming. But

Environmental SOS: Rare Birds Crunch From Bellies Full of Plastic

SATURDAY, May 24, 2025 Birds on a remote Australian island are so full of plastic they crunch, British researchers report.They found plastic in the bellies of c

FDA Approves Nucala for Chronic Obstructive Pulmonary Disease

The U.S. Food and Drug Administration has approved Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with inadequately controlled chron